As life expectancy increases, so does the amount of financial planning needed to sustain a comfortable retirement. The latest research reveals that the majority of Americans approaching their senior years are both overconfident in their financial position and under informed about the skills and strategy needed to make their assets last. Six in ten people (62%) aged 50+ today provide financial support to family members and 5.8 million children live in grandparents' homes throughout the U.S, but a study conducted by the American College of Financial Services found that only 11% of retirement-age women could pass a basic quiz on how to make their retirement assets last through the rest of their lifetime. Most people surveyed were unsure when was the appropriate time to claim social security and the '4%' rule was a mystery to 70 percent of those nearing retirement stage. So what are the solutions and how can people best prepare themselves for their post work years? Amelia Martyn-Hemphill speaks with David Littell, RICP Retirement Income Program Director at The American College of Financial Services to find out what tools and strategies Americans need to know about when planning for retirement and the future.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.